1. Home
  2. CLAR vs CRDF Comparison

CLAR vs CRDF Comparison

Compare CLAR & CRDF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Clarus Corporation

CLAR

Clarus Corporation

HOLD

Current Price

$3.66

Market Cap

104.9M

ML Signal

HOLD

Logo Cardiff Oncology Inc.

CRDF

Cardiff Oncology Inc.

HOLD

Current Price

$1.04

Market Cap

86.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CLAR
CRDF
Founded
1957
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Recreational Games/Products/Toys
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
104.9M
86.8M
IPO Year
1998
2012

Fundamental Metrics

Financial Performance
Metric
CLAR
CRDF
Price
$3.66
$1.04
Analyst Decision
Buy
Strong Buy
Analyst Count
3
4
Target Price
$4.08
$9.63
AVG Volume (30 Days)
134.6K
699.6K
Earning Date
05-07-2026
05-07-2026
Dividend Yield
3.80%
N/A
EPS Growth
11.68
27.37
EPS
0.04
N/A
Revenue
$228,000.00
$365,993.00
Revenue This Year
$5.27
N/A
Revenue Next Year
$3.99
N/A
P/E Ratio
$93.00
N/A
Revenue Growth
N/A
49.61
52 Week Low
$2.53
$0.76
52 Week High
$4.03
$3.31

Technical Indicators

Market Signals
Indicator
CLAR
CRDF
Relative Strength Index (RSI) 53.15 54.44
Support Level $3.52 $0.87
Resistance Level $3.71 $1.13
Average True Range (ATR) 0.11 0.07
MACD -0.02 0.02
Stochastic Oscillator 33.33 77.83

Price Performance

Historical Comparison
CLAR
CRDF

About CLAR Clarus Corporation

Clarus Corp is a designer, developer, manufacturer, and distributor of outdoor equipment and lifestyle products focused on the climb, ski, mountain, sport, and skincare markets. The company operates through the Outdoor segment, which includes Black Diamond Equipment and PIEPS, is a world-wide leader in designing, manufacturing, and marketing outdoor engineered equipment and apparel for climbing, mountaineering, trail running, backpacking, skiing, and a wide range of other year-round outdoor recreation activities. The Adventure segment, which includes Rhino-Rack, MAXTRAX and TRED, is a manufacturer of engineered automotive roof racks, trays, mounting systems, luggage boxes, carriers, recovery boards and accessories in Australia and New Zealand and U.S.

About CRDF Cardiff Oncology Inc.

Cardiff Oncology Inc is a clinical-stage biotechnology company that leverages PLK1 inhibition, a well-validated oncology drug target, to develop novel therapies for various cancers with unmet medical needs. The company focuses on targeting tumor vulnerabilities with treatment combinations of onvansertib, its oral and selective PLK1 inhibitor, and standard-of-care (SoC) therapeutics. The firm's clinical program pipeline focuses on indications such as RAS-mutated metastatic colorectal cancer (mCRC), investigator-initiated trials in metastatic pancreatic ductal adenocarcinoma (mPDAC), small cell lung cancer (SCLC), metastatic triple negative breast cancer (mTNBC), and Chronic Myelomonocytic Leukemia (CMML). Geographically, it operates only in the United States.

Share on Social Networks: